title: The costs of diabetic foot: the economic case for the limb salvage team.
abstract: In 2007, the treatment of diabetes and its complications in the United States generated at least $116 billion in direct costs; at least 33% of these costs were linked to the treatment of foot ulcers. Although the team approach to diabetic foot problems is effective in preventing lower-extremity amputations, the costs associated with implementing a diabetic-foot-care team are not well understood. An analysis of these costs provides the basis for this report. Diabetic foot problems impose a major economic burden, and costs increase disproportionately to the severity of the condition. Compared with diabetic patients without foot ulcers, the cost of care for those with foot ulcers is 5.4 times higher in the year after the first ulcer episode and 2.8 times higher in the second year. Costs for treating the highest-grade ulcers are 8 times higher than are those for treating low-grade ulcers. Patients with diabetic foot ulcers require more frequent emergency department visits and are more commonly admitted to the hospital, requiring longer lengths of stay. Implementation of the team approach to manage diabetic foot ulcers in a given region or health-care system has been reported to reduce long-term amputation rates 62% to 82%. Limb salvage efforts may include aggressive therapy such as revascularization procedures and advanced wound-healing modalities. Although these procedures are costly, the team approach gradually leads to improved screening and prevention programs and earlier interventions and, thus, seems to reduce long-term costs. To date, aggressive limb preservation management for patients with diabetic foot ulcers has not usually been paired with adequate reimbursement. It is essential to direct efforts in patient-caregiver education to allow early recognition and management of all diabetic foot problems and to build integrated pathways of care that facilitate timely access to limb salvage procedures. Increasing evidence suggests that the costs of implementing diabetic foot teams can be offset in the long term by improved access to care and reductions in foot complications and amputation rates.
authors.affiliation: Department of Surgery, Boston Medical Center and Boston University School of Medicine, Boston, MA 02118, USA. vickie.driver@bmc.org
authors.forename: Vickie R
authors.initials: VR
authors.lastname: Driver
authors.forename: Matteo
authors.initials: M
authors.lastname: Fabbi
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Lavery
authors.forename: Gary
authors.initials: G
authors.lastname: Gibbons
mesh_terms: D017281:Cost of Illness; D048909:Diabetes Complications / Q000191:economics; D017719:Diabetic Foot / Q000191:economics* / Q000628:therapy*; D019468:Disease Management; D006801:Humans; D023821:Limb Salvage / Q000191:economics*; D006278:Medicare / Q000191:economics; D010348:Patient Care Team / Q000191:economics; D014481:United States